Patricia Conrod , Ph.D.
    Patricia Conrod
    Research Axis
    Brain and Child Development Axis
    Research Theme
    Development of psychopathologies
    CHUSJ - Centre de Recherche

    514 345-4931 4051



    • Full Professor, Department of Psychiatry and Addictology, Université de Montréal
    • Université de Montréal’s Dr. Julien/Marcelle and Jean Coutu Foundation Chair in Community Social Pediatrics          

    Internship opportunity(ies)


    • PhD, Clinical Psychology, McGill University, 1998
    • BA, Psychology (First Class Honours), McGill University, 1992


    Conrodventure Lab


    Research Interests

    Patricia Conrod is a Clinical Psychologist and Professor of Psychiatry at Universite de Montreal. Her research team is based at the CHU Sainte-Justine Mother and Child Hospital Centre in Montreal. She was previously a Senior Clinical Lecturer in the Addictions Department, King’s College London (2003-2010). Her research focuses on cognitive, personality and biological risk factors for the development and maintenance of drug abuse and the factors that mediate the co-occurrence of addictive behaviours with other mental disorders. Her research findings have led to the development of new approaches to substance abuse treatment and prevention that target personality risk factors and the underlying motivational determinants of drug use in subtypes of substance misusers. She developed the Preventure Program, which is identified as an evidence-based drug and alcohol prevention program by a number of national registries of evidence-based programs and the U.S. Surgeon General’s Report on Addiction.  Dr. Conrod was a member of the King’s College London Research Ethics Committee (2005-2010) and served as Chair of the Institute of Psychiatry Research Ethics Committee (2008-2010).  She is an Associate Editor of Current Reviews in Drug Abuse and consults to the UN and the European Commission on guidelines for drug and alcohol prevention and has published extensively on this issue. Her research is funded by the Canadian Institutes of Health Research, Fondation de Recherche du Quebec - Santé, European Commission (Health and Humanities/Social Sciences), Medical Research Council-UK (MRC), National Health and Medical Research Council - Australia (NHMRC), and the U.S. National Institutes of Health.

    Research Topics

    • Adolescent Brain Development
    • Prevention
    • Addiction
    • Personality
    • Clinical trials
    • Cognitive Behavioural Therapy

    Awards and Distinctions

    • Université de Montréal’s Dr. Julien/Marcelle and Jean Coutu Foundation Chair in Community Social Pediatrics, Montreal, QC, 2015-2019
    • Fonds de Recherche en Santé du Québec, Salary Career Award, 2013-2017.
    • Chercheur Boursier – Junior2, Fondation de Recherche en Santé du Quebec, Canada. 2010-2013  
    • National Health & Medical Research Council (NHMRC), Research Grant, 2011-2016.
    • Medical Research, Research Grant, UK, 2010-2015
    • Fonds de Recherche en Santé du Québec (FRSQ), Research Scholar, 2010-2013
    • Vice Chancellor Post Doctorate Research Fellowship, 
    • Action on Addiction Research Fellow, Institute of Psychiatry, King’s College London, London, UK, 2003-2008
    • Postdoctoral Fellowship, Social Sciences and Humanities Research Council of Canada (SSHRC), 1998-2000
    • Doctoral Fellowship, Medical Research Council of Canada (MRC), 1995-1997
    • Doctoral Fellowship, Medical Research Council of Canada (MRC), 1993-1995
    • Doctoral Fellowship, Fond pour la Formation de Chercheurs et l'aide à la recherche (FCAR), 1993-1995 
    • Doctoral Fellowship, Medical Research Council of Canada (MRC), 1992-1993
    • Doctoral Fellowship, Fond pour la Formation de Chercheurs et l'Aide à la Recherche (FCAR), 1992-1993
    • University Scholar, BA, McGill University, Montreal, QC, 1992
    • Faculty Scholar, BA, McGill University, Montreal, QC, 1992
    • James McGill Award, BA, McGill University, Montreal, QC, 1991

    Major financing

    Canadian Institutes of Health Research (CIHR), ERA-NET, Fonds de recherche du Québec – Santé (FRSQ), U.S. National Institutes of Health, Medical and Health Research Council – Australia.


    • Conrod, P.J., (2017).  Innovation in Drug and Alcohol Prevention.  Plenary Address at the 35th Annual Research Seminar of the National Drug and Alcohol Research Centre, Sydney Australia.
    • Conrod, P.J. (2015).  Neurocognitive Correlates of the Variance Common and Unique to Externalising Disorders and Substance Misuse in Adolescence (and the Efficacy of Interventions Targeting these Neurocognitive Profiles). NIAAA NIDA Mini Convention, Frontiers in Addiction Research: Neurobiological and Behavioral Consequences of Drug and Alcohol Use during Development.
    • Conrod, P.J. (2015) Interventions targeting impulsivity and sensation seeking for youth substance use and externalizing problems.  Invited plenary address. 11th Annual ADHD Conference, Canadian ADHD Resource Alliance,  October 17  - 18, 2015  Vancouver Marriott Pinnacle Downtown Hotel, Vancouver, BC
    • Conrod, P.J – (2015) Invited Speaker.  Personality-Targeted interventions for youth substance use and mental health problems: preventative effects and youth subjective experiences. Third International Youth Mental Health Conference 2015, Place des Arts, Montreal, Canada 8th–10th October 2015
    • Conrod, P.J. (2013). Individual and population-level benefits of targeting impulsivity in school-based interventions.  Grand Rounds Address, Department of Psychiatry, University of Vermont, Nov, 2013.


    • Edalati H, Afzali MH, Spinney S, Bourque J, Dagher A, Conrod PJ. A longitudinal mediation study of peer victimization and resting-state functional connectivity as predictors of development of adolescent psychopathology. Front Psychiatry. 2023 Mar 23;14:1099772. doi: 10.3389/fpsyt.2023.1099772. PMID: 37032939; PMCID: PMC10076669.
    • Newton NC, Debenham J, Slade T, Smout A, Grummitt L, Sunderland M, Barrett EL, Champion KE, Chapman C, Kelly E, Lawler S, Castellanos-Ryan N, Teesson M, Conrod PJ, Stapinski L. Effect of Selective Personality-Targeted Alcohol Use Prevention on 7-Year Alcohol-Related Outcomes Among High-risk Adolescents: A Secondary Analysis of a Cluster Randomized Clinical Trial. JAMA Netw Open. 2022 Nov 1;5(11):e2242544. doi: 10.1001/jamanetworkopen.2022.42544. PMID: 36394873; PMCID: PMC9672969.
    • Assaf R, Ouellet J, Bourque J, Stip E, Leyton M, Conrod P, Potvin S. A functional neuroimaging study of self-other processing alterations in atypical developmental trajectories of psychotic-like experiences. Sci Rep. 2022 Sep 29;12(1):16324. doi: 10.1038/s41598-022-20129-3. PMID: 36175570; PMCID: PMC9522794.
    • Nairn SA, Audet M, Stewart SH, Hawke LD, Isaacs JY, Henderson J, Saah R, Knight R, Fast D, Khan F, Lam A, Conrod P. Interventions to Reduce Opioid Use in Youth At-Risk and in Treatment for Substance Use Disorders: A Scoping Review. Can J Psychiatry. 2022 Dec;67(12):881-898. doi: 10.1177/07067437221089810. Epub 2022 May 9. PMID: 35535396; PMCID: PMC9659799.
    • Conrod PJ. Cannabis and Brain Health: What Is Next for Developmental Cohort Studies? Am J Psychiatry. 2022 May;179(5):317-318. doi: 10.1176/appi.ajp.20220245. PMID: 35491566.
    • Navarri X, Afzali MH, Lavoie J, Sinha R, Stein DJ, Momenan R, Veltman DJ, Korucuoglu O, Sjoerds Z, van Holst RJ, Hester R, Orr C, Cousijn J, Yucel M, Lorenzetti V, Wiers R, Jahanshad N, Glahn DC, Thompson PM, Mackey S, Conrod PJ. How do substance use disorders compare to other psychiatric conditions on structural brain abnormalities? A cross-disorder meta-analytic comparison using the ENIGMA consortium findings. Hum Brain Mapp. 2022 Jan;43(1):399-413. doi: 10.1002/hbm.25114. Epub 2020 Jul 9. PMID: 32643841; PMCID: PMC8675406.
    • Boers E, Afzali MH, Newton N, Conrod P. Association of Screen Time and Depression in Adolescence. JAMA Pediatr. 2019 Sep 1;173(9):853-859. doi: 10.1001/jamapediatrics.2019.1759. PMID: 31305878; PMCID: PMC6632122.
    • Afzali MH, Sunderland M, Stewart S, Masse B, Seguin J, Newton N, Teesson M, Conrod P. Machine-learning prediction of adolescent alcohol use: a cross-study, cross-cultural validation. Addiction. 2019 Apr;114(4):662-671. doi: 10.1111/add.14504. Epub 2018 Dec 21. PMID: 30461117.
    • Morin JG, Afzali MH, Bourque J, Stewart SH, Séguin JR, O'Leary-Barrett M, Conrod PJ. A Population-Based Analysis of the Relationship Between Substance Use and Adolescent Cognitive Development. Am J Psychiatry. 2019 Feb 1;176(2):98-106. doi: 10.1176/appi.ajp.2018.18020202. Epub 2018 Oct 3. PMID: 30278790.
    • Bourque J, Afzali MH, Conrod PJ. Association of Cannabis Use With Adolescent Psychotic Symptoms. JAMA Psychiatry. 2018 Aug 1;75(8):864-866. doi: 10.1001/jamapsychiatry.2018.1330. PMID: 29874357; PMCID: PMC6584279.
    • Afzali MH, Sunderland M, Carragher N, Conrod P. The Structure of Psychopathology in Early Adolescence: Study of a Canadian Sample: La structure de la psychopathologie au début de l'adolescence: étude d'un échantillon canadien. Can J Psychiatry. 2018 Apr;63(4):223-230. doi: 10.1177/0706743717737032. Epub 2017 Oct 23. PMID: 29061067; PMCID: PMC5894914.
    • O'Leary-Barrett M, Mâsse B, Pihl RO, Stewart SH, Séguin JR, Conrod PJ. A cluster-randomized controlled trial evaluating the effects of delaying onset of adolescent substance abuse on cognitive development and addiction following a selective, personality-targeted intervention programme: the Co-Venture trial. Addiction. 2017 Oct;112(10):1871-1881. doi: 10.1111/add.13876. Epub 2017 Jul 17. Erratum in: Addiction. 2018 Mar;113(3):581. PMID: 28544009.
    • Anderson P, Berridge V, Conrod P, Dudley R, Hellman M, Lachenmeier D, Lingford-Hughes A, Miller D, Rehm J, Room R, Schmidt L, Sullivan R, Ysa T, Gual A. Reframing the science and policy of nicotine, illegal drugs and alcohol - conclusions of the ALICE RAP Project. F1000Res. 2017 Mar 17;6:289. doi: 10.12688/f1000research.10860.1. PMID: 28435669; PMCID: PMC5381624.
    • Bourque J, Spechler PA, Potvin S, Whelan R, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Quinlan EB, Desrivières S, Flor H, Frouin V, Gowland P, Heinz A, Ittermann B, Martinot JL, Paillère-Martinot ML, McEwen SC, Nees F, Orfanos DP, Paus T, Poustka L, Smolka MN, Vetter NC, Walter H, Schumann G, Garavan H, Conrod PJ; IMAGEN Consortium. Functional Neuroimaging Predictors of Self-Reported Psychotic Symptoms in Adolescents. Am J Psychiatry. 2017 Jun 1;174(6):566-575. doi: 10.1176/appi.ajp.2017.16080897. Epub 2017 Mar 21. PMID: 28320226; PMCID: PMC5951182.
    • Baker TE, Lesperance P, Tucholka A, Potvin S, Larcher K, Zhang Y, Jutras-Aswad D, Conrod P. Reversing the Atypical Valuation of Drug and Nondrug Rewards in Smokers Using Multimodal Neuroimaging. Biol Psychiatry. 2017 Dec 1;82(11):819-827. doi: 10.1016/j.biopsych.2017.01.015. Epub 2017 Jan 27. PMID: 28314439.
    • Conrod PJ, Nikolaou K. Annual Research Review: On the developmental neuropsychology of substance use disorders. J Child Psychol Psychiatry. 2016 Mar;57(3):371-94. doi: 10.1111/jcpp.12516. PMID: 26889898.
    • Mahu IT, Doucet C, O'Leary-Barrett M, Conrod PJ. Can cannabis use be prevented by targeting personality risk in schools? Twenty-four-month outcome of the adventure trial on cannabis use: a cluster-randomized controlled trial. Addiction. 2015 Oct;110(10):1625-33. doi: 10.1111/add.12991. Epub 2015 Jul 14. PMID: 26011508; PMCID: PMC5034824.
    • Castellanos-Ryan N, Struve M, Whelan R, Banaschewski T, Barker GJ, Bokde AL, Bromberg U, Büchel C, Flor H, Fauth-Bühler M, Frouin V, Gallinat J, Gowland P, Heinz A, Lawrence C, Martinot JL, Nees F, Paus T, Pausova Z, Rietschel M, Robbins TW, Smolka MN, Schumann G, Garavan H, Conrod PJ; IMAGEN Consortium. Neural and cognitive correlates of the common and specific variance across externalizing problems in young adolescence. Am J Psychiatry. 2014 Dec 1;171(12):1310-9. doi: 10.1176/appi.ajp.2014.13111499. Epub 2014 Oct 31. PMID: 25073448.
    • Conrod PJ, O'Leary-Barrett M, Newton N, Topper L, Castellanos-Ryan N, Mackie C, Girard A. Effectiveness of a selective, personality-targeted prevention program for adolescent alcohol use and misuse: a cluster randomized controlled trial. JAMA Psychiatry. 2013 Mar;70(3):334-42. doi: 10.1001/jamapsychiatry.2013.651. PMID: 23344135.
    • Whelan R, Conrod PJ, Poline JB, Lourdusamy A, Banaschewski T, Barker GJ, Bellgrove MA, Büchel C, Byrne M, Cummins TD, Fauth-Bühler M, Flor H, Gallinat J, Heinz A, Ittermann B, Mann K, Martinot JL, Lalor EC, Lathrop M, Loth E, Nees F, Paus T, Rietschel M, Smolka MN, Spanagel R, Stephens DN, Struve M, Thyreau B, Vollstaedt-Klein S, Robbins TW, Schumann G, Garavan H; IMAGEN Consortium. Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci. 2012 Jun;15(6):920-5. doi: 10.1038/nn.3092. PMID: 22544311.

Grow Beyond our wildest dreams

With the support of donors like you, at the heart of the Grow Beyond campaign, we are leading healthcare teams towards the opportunities offered by science and new technologies, so that every child, no matter where in Quebec, has access to the unique expertise and know-how of CHU Sainte-Justine. Together, let's join forces for their future.

Grow Beyond with us.

Contact Us

514 345-4931


© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security


Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine